
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+10
Shuimu is a rapidly evolving global cryo-EM & AI platform for early drug discovery, founded in 2017 and headquartered in Beijing, China. Shuimu drives innovation to accelerate the development of innovative drugs. Shuimu leverages the power of cutting-edge cryo-EM & AI technology to help its partners gain key structural insights into the target proteins and complexes. The team consists of top talents with global backgrounds in the field of structural biology, machine learning, protein science, and drug chemistry. Learn more about Shuimu and check out its cryo-EM precision imaging platform by visiting shuimubio.com or sending an email to hi@shuimubio.com
Drug discovery,cryo-em,microed,drugdevelopment,proteinstructure,biophysics,antibodies,virology,nanoparticles,aav,structuralbiology,cro,ppi,exosomes,and liposomes
Shuimu biosciences operates in the Biotechnology research industry.
Shuimu biosciences's revenue is 11m - 100m
Shuimu biosciences has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.